Science AI Journal
Medicine · Research topic

Open research questions in Helicobacter pylori-related gastroenterology studies

602 gap statements mined from Helicobacter pylori-related gastroenterology studies papers in our 7.9M-paper local library, which holds 2,333 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.

Choosing where to publish on Helicobacter pylori-related gastroenterology studies? See the ranked Medicine journals.

What the literature leaves open

  • The lack of a comprehensive dataset for gastritis classification through endoscopy. The challenge of accurately identifying and characterizing gastritis patterns through endoscopy. The need for a reliable dataset for multi-task automatic gastritis analysis.

    EGID: A Comprehensive Multi-label Endoscopic Image Dataset for Gastritis Classification · 2026 · DOI

  • VacA has experimentally documented cellular effects, including vacuolization, mitochondrial dysfunction, and immunomodulation; their direct contribution to the microbiota patterns reported in human observational studies remains to be established.

    Association of Helicobacter pylori Infection with the Gastric Microbiota: A Scoping Review from a Molecular Diagnostic Perspective · 2026 · DOI

  • PPUMS was developed recently and, to our knowledge, has not been evaluated in an independent cohort beyond the split-sample internal validation reported in the original study.

    Comparative Discrimination of Boey, PULP, and PPUMSs for Textbook Outcome Failure, Failure-to-Rescue, and 30-Day Mortality Following Perforated Peptic Ulcer Surgery · 2026 · DOI

  • Importantly, future studies should incorporate formal health-economic and cost-effectiveness evaluations alongside diagnostic accuracy and clinical utility to determine the feasibility and value of integrating AI-assisted multi-omics into routine gastroscopic and biopsy workflows.

    Transforming Gastric Biopsy Diagnostics: Integrating Omics Technologies and Artificial Intelligence · 2026 · DOI

  • Although gut barrier dysfunction has long been implicated in the pathophysiology of sepsis, the temporal behavior of plasma TFF3 levels has not been fully explored in pediatric patients with sepsis.

    Trefoil factor 3 as a marker of gastrointestinal cell injury during sepsis · 2026 · DOI

  • Our current knowledge in this field, however, is limited. Future preclinical and clinical studies investigating the role of H. pylori-associated effects on mitochondrial stress, mtROS, mitochondrial metabolism, and mitochondrial dynamics may lead to new therapeutic targets in these malignancies.

    Mitochondrial Stress in Helicobacter pylori Infection and Associated Malignancies: A Review · 2026 · DOI

  • Existing animal models can replicate features of human AIG but exhibit significant limitations regarding the mechanism of T-B cell collaboration. The mechanism of T-B cell collaboration is not fully understood. Differences in cancer risk and species specificity are not well studied.

    Immunological mechanisms of autoimmune gastritis · 2026 · DOI

  • Whether increasing the dosage of MET up to 30 mg/kg (a maximum of 1500 mg daily) can achieve an eradication rate exceeding 90% in children warrants further investigation. Future prospective longitudinal cohort studies are warranted to continuously monitor eradication durability, local resistance trends and re-infection risk, so as to further validate the real-world long-term value of this regimen.

    Bismuth-containing quadruple therapy for Helicobacter pylori infection in penicillin‑allergic children: efficacy, safety and real‑world experience from China · 2026 · DOI

  • Limited understanding of the application of traditional Chinese medicine in managing CAG. Need for new interventions to prevent the progression of CAG toward gastric cancer.

    Integrated bulk and single-cell transcriptomics with virtual knockout analysis identifies FOS as an epithelial-associated candidate gene in chronic atrophic gastritis · 2026 · DOI

  • The limited understanding of the molecular mechanisms underlying H. pylori-induced PANoptosis in the gastric mucosa. The need to develop effective therapeutic strategies to target the TRAF1/OASL/ZBP1-PANoptosome pathway in GC cells.

    Helicobacter pylori activates the TRAF1/OASL/ZBP1-PANoptosome pathway to induce PANoptosis in the gastric mucosa · 2026 · DOI

  • Culture-free alternatives have been limited by the extremely low Hp abundance in gastric tissue (usually 10-3 to 10-7 of total genomic DNA), making direct metagenomics prohibitively expensive and existing enrichment strategies insufficient for whole-genome recovery.

    Culture-free Helicobacter pylori genomics reveals within-host virulence heterogeneity and antibiotic resistance · 2026 · DOI

  • The lack of direct comparisons between vonoprazan dual therapy and bismuth-containing quadruple therapy. The need for effective treatments due to increasing antibiotic resistance.

    Randomized trial of vonoprazan dual therapy vs bismuth-containing quadruple therapy with two low-resistance antibiotics for Helicobacter pylori eradication · 2026 · DOI

  • Meanwhile, some results were not consistent across the studies in this review; thus, further studies remain warranted in this field.

    The Impact of Tobacco Smoking and Alcohol Consumption on the Development of Gastric Cancers · 2024 · DOI

  • It is necessary to encourage additional progress in the clinical management of gastritis patients. The following crucial RE.GA.IN consensus statements should be noted: 1. Depending on variables such as etiology and stage, there are varying degrees of risk associated with the preneoplastic condition known as gastritis.

    Helicobacter pylori Infection in Patients with Gastric Cancer: A 2024 Update · 2024 · DOI

  • Moreover, although data on the combination therapy of anti-TNF-α biological monotherapy are scarce, US guidelines recommend combining biologics to enhance the therapeutic response.

    Lactate Protects Intestinal Epithelial Barrier Function from Dextran Sulfate Sodium-Induced Damage by GPR81 Signaling · 2024 · DOI

  • The long-term effects of omeprazole on cobalamin and serum gastrin levels in healthy dogs are not well understood. Current guidelines do not recommend the routine use of omeprazole for managing gastritis, pancreatitis, liver disease, or kidney disease in dogs and cats without additional risk factors.

    Prospective Randomized Controlled Clinical Trial of the Long-Term Effects of Omeprazole on Healthy Dogs · 2024 · DOI

  • The lack of effective alternative treatments for H. pylori infection. The need for probiotics that can inhibit H. pylori activity and colonization. The limited understanding of the effects of probiotics on H. pylori infection in humans.

    Screening Probiotics for Anti-Helicobacter pylori and Investigating the Effect of Probiotics on Patients with Helicobacter pylori Infection · 2024 · DOI

  • Third, TFF3 levels were measured at a single time point upon admission, and serial measurements were not performed; therefore, the temporal dynamics of TFF3 in relation to disease progression could not be assessed.

    Trefoil factor 3 as a marker of gastrointestinal cell injury during sepsis · 2026 · DOI

  • Being an initiator of immune response and inflammation, IFN-g activates STAT1, which enhances antimicrobial action in addition to causing chronic inflammation that may lead to the transformation of gastric epithelial cells. This duality underlines the intricacy of STAT1’s role in carcinogenesis and the importance of delicate therapeutic solutions.

    The STAT1 lexicon: translating signaling codes in H. pylori-driven gastric carcinogenesis · 2026 · DOI

  • Ongoing research into the gastric microbiome has expanded our knowledge of how H.

    Modern possibilities of molecular diagnostics contribute to improving the effectiveness of therapy against Helicobacter pylori · 2026 · DOI

  • The approaches described in this review are supposed to offer a new diagnostic possibility for GPC and, as an effect, help decrease GC mortality in the near future.

    Non-Invasive Markers for the Detection of Gastric Precancerous Conditions · 2024 · DOI

  • A systematic elucidation of the complete functional spectrum of humoral immunity in AIG is needed - Future studies should prioritize the investigation of the specific subtype profiles, class-switching, and relationship with disease stages…

    Immunological mechanisms of autoimmune gastritis · 2026 · DOI

  • Potential off-target effects of shRNA and siRNA, despite using multiple sequences, warrant future CRISPR-Cas9 validation - Variability between GC cell lines suggests our findings should be verified in broader models - Z-VAD-FMK and LPS are not specific PANoptosis modulators; their broad effects mean more targeted methods are needed to precisely delineate the PANoptosis…

    Helicobacter pylori activates the TRAF1/OASL/ZBP1-PANoptosome pathway to induce PANoptosis in the gastric mucosa · 2026 · DOI

  • Further studies to compare VA dual therapy with other BQT regimens, - Research on the long-term efficacy and safety of VA dual therapy, - Studies to evaluate the cost-effectiveness of VA dual therapy in different healthcare…

    Randomized trial of vonoprazan dual therapy vs bismuth-containing quadruple therapy with two low-resistance antibiotics for Helicobacter pylori eradication · 2026 · DOI

  • Major gaps remain regarding the bacterium's genomic, metabolic, and population-level variations, - Phenotypic methods present several practical challenges, - Sanger sequencing is a highly technical procedure that requires specialized training and a substantial investment…

    Modern possibilities of molecular diagnostics contribute to improving the effectiveness of therapy against Helicobacter pylori · 2026 · DOI

Most-cited papers in Helicobacter pylori-related gastroenterology studies

Most recent work

Find a gap in your own Helicobacter pylori-related gastroenterology studies sub-topic

This page shows what the Helicobacter pylori-related gastroenterology studies literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.

Open the Research Gap Finder →

Related topics in Medicine

Artificial Intelligence in Healthcare and Education
4,869 open questions
Dementia and Cognitive Impairment Research
3,297 open questions
Cancer Immunotherapy and Biomarkers
2,687 open questions
Liver Disease Diagnosis and Treatment
2,481 open questions
Substance Abuse Treatment and Outcomes
2,366 open questions
Sports Performance and Training
2,276 open questions
Mosquito-borne diseases and control
2,124 open questions
Parkinson's Disease Mechanisms and Treatments
2,117 open questions
Open questions raised by papers listed on this page include: (1) The lack of a comprehensive dataset for gastritis classification through endoscopy (“EGID: A Comprehensive Multi-label Endoscopic Image Dataset for Gastritis…”, 2026); (2) Although gut barrier dysfunction has long been implicated in the pathophysiology of sepsis, the temporal behavior of plasma TFF3 levels has not been fully explored in pediatric patients with sepsis (“Trefoil factor 3 as a marker of gastrointestinal cell injury during sepsis”, 2026); (3) The mechanism of T-B cell collaboration is not fully understood (“Immunological mechanisms of autoimmune gastritis”, 2026); (4) Future prospective longitudinal cohort studies are warranted to continuously monitor eradication durability, local resistance trends and re-infection risk, so as to further validate the real-world long-term value of this regimen (“Bismuth-containing quadruple therapy for Helicobacter pylori infection in…”, 2026); (5) The lack of direct comparisons between vonoprazan dual therapy and bismuth-containing quadruple therapy (“Randomized trial of vonoprazan dual therapy vs bismuth-containing quadruple…”, 2026). 602 gap statements have been mined from Helicobacter pylori-related gastroenterology studies papers in our 7.9M-paper local library, which holds 2,333 papers on the topic; the gaps come from whichever of those papers state one. They are mostly the research gaps the authors state and the papers' abstracts, plus future-work, limitations and challenges passages. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one, so you can read the original claim in context.

Tools for your next paper

Gaps & Literature SearchFind open questions in any field — 1,100,000+ open gaps mined from our own library.Pre-CheckIs your paper ready? Acceptance odds for top, mid and open/emerging journals, in seconds.Journal FinderA ranked shortlist of target journals from a 17,500-venue index.Duplicate Publication CheckerCheck for prior publication across 7 sources and our local library.Citation GeneratorFreeA DOI or title → APA, MLA, Vancouver, Chicago, BibTeX, RIS. No signup.Graphical Abstract MakerFreeTurn your findings into a colorblind-safe graphical abstract.

How Pre-Check worksHow AI Review works

Compare the category — Honest roundups of the AI research tools, ours listed alongside the alternatives.

Command palette

Jump anywhere, run any action.